Stay updated with breaking news from Device Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
San Francisco, CA (PRWEB) May 10, 2022 -- Amprion announces the National Institute of Neurological Disorders and Stroke (NINDS) has awarded an additional
Cognito Therapeutics Joins Digital Medicine Society’s (DiMe) Alzheimer's Disease and Related Dementias Project to Advance Next-Generation Clinical Measures - read this article along with other careers information, tips and advice on BioSpace
Under the deal, MedRhythms would receive a $3 million upfront payment and could earn up to $117.5 million if certain milestones are met.
Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.
With the partnership, doulas will be able to refer their Medicaid patients to Brave for mental health services like therapy, psychiatry and medication management.